Straddle
A straddle is an options strategy consisting of simultaneously buying (long straddle) or selling (short straddle) a call and a put on the same underlying asset with identical strike prices and expiration dates. The long straddle profits from large price moves in either direction, while the short straddle profits when the underlying remains near the strike through expiration.
Key takeaways
- A long straddle requires the underlying asset to move beyond the combined premium paid in either direction to achieve profitability.
- The maximum loss on a long straddle is limited to the total premium paid; the maximum profit is theoretically unlimited on the upside.
- Short straddles generate premium income but expose the seller to unlimited loss if the underlying moves significantly in either direction.
- Implied volatility is the primary driver of straddle pricing; traders often buy straddles when they expect realized volatility to exceed implied volatility.
- The breakeven points of a long straddle are the strike price plus and minus the total premium paid.
Explanation
The straddle is one of the most fundamental volatility trading strategies in the derivatives toolkit. Unlike directional trades that require a view on the price level of an asset, a straddle expresses a pure view on volatility—specifically, whether future realized volatility will be greater than (long straddle) or less than (short straddle) the implied volatility embedded in option prices at the time of trade. This volatility-centric framing makes straddles central to the volatility arbitrage strategies employed by hedge funds, options market makers, and structured products desks.
For a long straddle, the profit at expiration is max(S_T − K, 0) + max(K − S_T, 0) − (C + P), where S_T is the terminal spot price, K is the strike price, C is the call premium, and P is the put premium. The upper breakeven is K + C + P and the lower breakeven is K − C + P. Between these two points, the position loses money, with maximum loss of C + P at exactly K. The structure is symmetric around the strike, making it particularly useful ahead of binary events such as earnings announcements, FDA drug approvals, or central bank policy decisions, where the direction of the move is uncertain but a large move is expected.
The Greeks of a long straddle are instructive: delta is approximately zero at inception (the long call's positive delta and the long put's negative delta cancel), gamma is strongly positive (the position becomes more directional as the underlying moves), vega is highly positive (the position benefits from increases in implied volatility), and theta is sharply negative (time decay erodes the position continuously). For short straddle sellers, the Greek profile is reversed: they collect theta but face negative gamma and negative vega, meaning sharp moves or volatility spikes are their adversaries.
In practice, hedge funds distinguish between pre-event and post-event straddle trades. A fund might purchase a straddle two weeks before a company's earnings release if implied volatility appears cheap relative to historical post-earnings moves. Conversely, volatility sellers who believe the market overprices uncertainty will short straddles ahead of events, collecting premium in exchange for risk. The realized-versus-implied volatility spread is the core P&L driver, often measured through the concept of variance risk premium.
An important nuance is the difference between an at-the-money (ATM) straddle and an at-the-money-forward (ATMF) straddle. In equity markets, the standard straddle uses the current spot price as the strike. In FX and interest rate markets, the convention shifts to the forward price as the reference point, ensuring the position is delta-neutral at inception under Black-Scholes assumptions. Sophisticated traders also manage straddles dynamically, delta-hedging the position daily to extract gamma profits independent of direction.
Formula
Straddle P&L = max(S_T − K, 0) + max(K − S_T, 0) − (C + P)
Example
Suppose shares of BioTech Corp are trading at $100 ahead of a pivotal FDA ruling. An at-the-money straddle with one month to expiration is priced with the call at $5.50 and the put at $5.00, for a total premium of $10.50 per share, or $1,050 per standard 100-share contract. The upper breakeven is $110.50 and the lower breakeven is $89.50. If the FDA approves the drug and the stock jumps to $130, the call is worth $30 and the put expires worthless, yielding a net profit of $30 − $10.50 = $19.50 per share, or $1,950 per contract. If the FDA rejects the drug and the stock falls to $75, the put is worth $25 and the call expires worthless, yielding a net profit of $25 − $10.50 = $14.50 per share. If the stock stays near $100, both options decay toward zero and the trader loses the full $10.50 premium.
Related terms
American Option Arbitrage At The Money Binary Option Black Scholes Model Central Bank Convergence Delta Equity Exchange Gamma Greeks